NRG1 and heart failure: GGF2 might also influence heart failure-associated muscle dysfunction via increased mir-30c-5p, which might represent a therapeutic target based on protection against myocardial ischemia-reperfusion injury in rats [90] and decreased plasma levels in patients with coronary heart disease [91].